GLPwatch
Trials (2167)
Page 11 of 37.
- Acute Effect of Exenatide on Brain Glucose Metabolism
- Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
- Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
- Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
- Glucagon-like Peptide (GLP) Utilization and Safety
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
- Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
- A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
- A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
- A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
- Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
- Pharmacogenetics of Response to GLP1R Agonists
- Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
- Comparing Facial Aging Between Identical Twins With 3D Imaging
- A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
- Exendin PET/CT for Imaging of Paragangliomas
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
- A Study of How CagriSema Works on Appetite in People With Excess Body Weight
- GLP1R in Parkinson's Disease
- Liraglutide Treatment in Obese Infertile PCOS Women
- Liraglutide in Type 1 Diabetes
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
- A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
- Liraglutide for HIV-associated Neurocognitive Disorder
- Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
- Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
- Imaging Pituitary ActiVation by Exendin
- A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
- GLP-1 Analogs for Neuroprotection After Cardiac Arrest
- Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
- Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
- A Study of IBI3046 in Participants With Overweight or Obesity
- Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
- Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
- 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
- Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
- TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
- Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
- Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
- A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
- Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
- Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Identifying Potential Effects of Liraglutide on Degenerative Changes
- GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
- Liraglutide in Spinal Fluid
- Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
- Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
- The Semaglutide Study
- The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.